Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 1, 2019
HTG Molecular Diagnostics to Announce First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9
TUCSON, Ariz., April 30, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM), a diagnostic company whose mission is to advance precision medicine, today announced ...
May 1, 2019
Chiasma to Report First Quarter Financial Results on May 9, 2019
WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and ...
May 1, 2019
Opiant Pharmaceuticals to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on Thursday, May 9
SANTA MONICA, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, ...
May 1, 2019
Theravance Biopharma to Report First Quarter 2019 Financial Results on May 7
DUBLIN, Ireland, April 30, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the ...
May 1, 2019
Checkpoint Therapeutics Announces Positive Interim Clinical Results of Anti-PD-L1 Antibody Cosibelimab
MONMOUTH JUNCTION, N.J., May 1, 2019 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and ...
May 1, 2019
Checkpoint Therapeutics Announces Positive Interim Clinical Results of Anti-PD-L1 Antibody Cosibelimab
NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
May 1, 2019
Zogenix to Release First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 8
EMERYVILLE, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will report ...
May 1, 2019
PolarityTE to Report Calendar First Quarter Financial Results on May 10, 2019
SALT LAKE CITY, May 1, 2019 /PRNewswire/ -- PolarityTE, Inc.(PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will ...
May 1, 2019
Arena Pharmaceuticals to Release First Quarter 2019 Financial Results and Provide Corporate Update on May 8
SAN DIEGO, May 1, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) will release its first quarter 2019 financial results and provide a corporate update on Wednesday, ...
May 1, 2019
Achieve TMS East Celebrates the Opening of its Dorchester Location
DORCHESTER, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East, Massachusetts’ largest provider of Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for the treatment ...
April 30, 2019
Kuros Biosciences to Propose Re-Appointment of Chairman and Board Members at Annual General Meeting
SCHLIEREN (ZURICH), Switzerland, April 30, 2019 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) will propose the re-appointment of Clemens van Blitterswijk as Chairman of the Board ...
April 30, 2019
Saniona publishes the Annual Report for 2018
Saniona (SANION.ST), a biotech company focused on the treatment of eating disorders and diseases of the central nervous system, announced today that the English version ...
April 30, 2019
RedHill Biopharma to Host First Quarter 2019 Financial Results Conference Call on May 7, 2019
TEL-AVIV, Israel and RALEIGH, N.C., April 30, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a ...
April 30, 2019
Avenue Therapeutics Announces Appointment of Dr. Thomas G. Moore to Board of Directors
NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (ATXI) (“Avenue”), a specialty pharmaceutical company focused on the development and commercialization of intravenous ...
April 30, 2019
Conatus Pharmaceuticals Announces Publication Demonstrating that Emricasan Ameliorates Portal Hypertension, Improves Liver Structure and Function in a Preclinical Model of Advanced Cirrhosis
SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT) today announced a new publication1 in Hepatology Communications detailing results following seven-day treatment ...
April 30, 2019
HTG Molecular Expands Agreement with Illumina to Include Autoimmune, Cardiovascular, and Fibrosis Disorders and Diseases
TUCSON, Ariz., April 30, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today ...
April 30, 2019
Eiger to Present at ChinaBio® Partnering Forum 2019
PALO ALTO, Calif., April 30, 2019 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for serious rare and ...
April 30, 2019
CymaBay Therapeutics to Report First Quarter 2019 Financial Results on Wednesday, May 8
NEWARK, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
April 30, 2019
Genocea Provides Corporate Update, Including First-Quarter 2019 Financial Results
CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today reported its operating and financial ...
April 30, 2019
Galmed Pharmaceuticals to Report First Quarter 2019 Financial Results and Provide Business Update on Tuesday, May 7
TEL AVIV, Israel, April 30, 2019 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the ...
Page 19 of 158